NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System Feedback from responses to FDA anticipated in 30 days Commercialization remains on track in first half of 2024 pending FDA clearance Product potential for transformative improvement in...

NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System  Potential for transformative improvement in neurosurgery as first known sEEG-guided RF system that records and ablates nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...